Home » Topics » Regulatory » Patents

Patents
RSS

Artax Biopharma patents TCR/NCK interaction inhibitors

May 14, 2015

Astellas Pharma discloses GABA(B) positive allosteric modulators

May 13, 2015

Shionogi prepares and tests ACC2 inhibitors

May 13, 2015

Dana-Farber, Syros Pharmaceuticals and Paraza Pharma jointly patent CDK7 inhibitors

May 13, 2015

Merck & Co. discloses ROM-K channel blockers

May 13, 2015

Roche patents CYP11B2 inhibitors

May 13, 2015

Retrophin introduces compounds for the treatment of neurodegeneration

May 13, 2015

Takeda discloses SSTR5 antagonists

May 12, 2015

Janssen patents new anti-HBV compounds

May 12, 2015

AbbVie patent reports development of GlyT-1 inhibitors

May 12, 2015

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
JPM 2026: Year kicks off with biopharma Q4 revenue and guidance
BioWorld
It was a battle of the companies with drugs for transthyretin-mediated amyloidosis on the first day of the J.P. Morgan 2026 Healthcare Conference with Alnylam...